Corporate Info Research Reports Consulting News Contact Us
 
<

 

Consulting Services

Let Cutting Edge Information help you build revenues, reduce costs, and increase efficiency.

Call Jason Richardson at 919-403-6583 today to learn more about our customized research and get a free quote.

REAL-COMPANY NEWS FROM CUTTING EDGE INFORMATION
Cutting Edge Information uses its news releases to quickly get information out to customers and research contacts. If you are interested in receiving up-to-date information about the latest findings from our business research, please let us know through the contact form here. 

2006:  Fourth Quarter | Third Quarter | Second Quarter | First Quarter

2005:  Fourth Quarter | Third Quarter | Second Quarter | First Quarter

2004: Fourth Quarter | Third Quarter | Second Quarter | First Quarter

2003: Fourth Quarter | Third Quarter | Second Quarter | First Quarter

2002: Fourth Quarter | Third Quarter | Second Quarter | First Quarter

Return to Current News

 

Fourth Quarter 2006

Five Signposts for Success: Post-Launch Pharmaceutical Marketing in the U.S.- A newly published benchmarking study on US post-launch marketing reveals five signposts for brand success...

New Report Analyzes Pharmaceutical Sales Training - Pharmaceutical business intelligence leader Cutting Edge Information announces the launch of a new report...

Average Pharma Brand: 38% of Sales Forgone to Adherence Issues - The average pharmaceutical brand forgoes 38% of its sales to adherence issues...

[ return to top ]

Third Quarter 2006

New Report Analyzes Pharma’s Handling of Investigator Initiated Clinical Trials - A new industry report, “Managing Investigator Initiated Clinical Trials: Structure, Process and Strategy”...

Blockbuster, Mid-Level and Niche Drugs Build Full Portfolios for Pharmaceutical and Biotechnology Companies - From $100 million specialty treatments to $10 billion blockbusters, pharma and biotech companies are searching for ways to better manage their drugs...

Continuing Medical Education (CME) Spending to Increase in 2007 - The pharmaceutical industry’s spending on continuing medical education (CME) is set to increase yet again in 2007...

New Report Benchmarks Pharmaceutical Clinical Development Spending and Staffing - Cutting Edge Information announces the launch of a new industry report, “Clinical Operations: Accelerating Trials, Allocating Resources and Measuring Performance”...

[ return to top ]

Second Quarter 2006

New One-Stop Marketing Resource Pushes Drug Companies Ahead of Competition - It’s simple: Drug companies have a unique pharmaceutical marketing problem and...

Breakthrough Primary Research Report Is Gateway to Medical Device Intelligence - Despite continual growth and increasing importance, there has been little business intelligence available to the medical device and diagnostic sector...

New Report Analyzes Pharmaceutical Market Segmentation Spending, Strategy and Implementation - Pharmaceutical business intelligence leader Cutting Edge Information announces the launch of a new report...

[ return to top ]

First Quarter 2006

3 Things Every Pharma Company Should Know About Reimbursement - Managed care and product reimbursement continue to grow in strategic importance to pharmaceutical and biotechnology industries...

Next-Generation Drug Development: Risky and Costly, But Worth It - Generic drugs, which drive a $40 billion dollar generics industry expected to hit $60 billion by 2007, account for 53% of all prescriptions filled in the United States today...

New Report Examines Top Pharmaceutical Co-Promotions and What Makes Them Successful - A new report by pharmaceutical intelligence firm Cutting Edge Information details the inner-workings of co-promotions at some of the industry’s top pharmaceutical companies...

Internal Struggles Plague Pharma Portfolio Management Teams - The greatest barriers to pharmaceutical portfolio management success come from within the organization...

[ return to top ]

Fourth Quarter 2005

Medical Science Liaisons: New Study Details Performance Measurement Systems - Cutting Edge Information, in collaboration with the Medical Science Liaison Institute, has just released its latest study on MSL programs that includes detailed performance measurement systems from top pharmaceutical companies ...

Pharmaceutical Advertising: United States vs. Europe - Pharmaceutical companies in Europe spend as much as 13% less on advertising than U.S. companies ...

New Report Dissects Pharmaceutical Strategic Pricing Departments - Cutting Edge Information announces the launch of a new report, “Pharmaceutical Pricing in the US and Europe: Analysis of Resources, Strategy and Structure” ...

Pharmaceutical Alliances Stumble on Little Things - Alliances and partnerships are common in the pharmaceutical and biotechnology industries, but successful unions are a little more rare ...

[ return to top ]

Third Quarter 2005

Pharma Sales: Training Today for Tomorrow’s Success  - The pharmaceutical industry is renowned for investing the time and money necessary to train its sales people to ...

Cutting Edge Information Launches New Report on European Pharmaceutical Marketing - Cutting Edge Information has recently launched a new report, “European Pharmaceutical Marketing: Launching Successful Brands,” that tracks the European marketing spending ...

Cancer Drugs Drive Pharmaceutical Success, Claim Marketing Dollars - Along with treatments for high cholesterol, ulcers and depression, cancer drugs have claimed their spot as key products ...

Authorized Generics Paves the Way for Lifecycle Management - A new study shows that global pharmaceutical companies invest and average $43 million to implement authorized generics strategies ...

Cover Story: Cutting Edge Information and Med Ad News Highlight the Most Successful Pharmaceutical Product Launches in 2004 - For a quick and comprehensive overview of what made a successful drug launch in 2004, see the cover of this month’s issue of Med Ad News ...

[ return to top ]

Second Quarter 2005

Medical Publications Spending Exceeds $6.5 Million for Blockbuster Pharmaceuticals - Pharmaceutical companies invest an average of $6.67 million in developing medical publications for blockbuster drugs ...

New Report Uncovers Oncology Marketing Factors - “Oncology Brand Commercialization: Resource Allocation,” identifies 28 critical variables for the marketing of cancer drugs. The report breaks down marketing spending and staff levels for each of these variables ...

Cutting Edge Information Sends President Jason Richardson to the ‘Building Better Brands’ Conference - Mr. Richardson will be presenting findings from the company’s latest Pharmaceutical Product Commercialization studies for the first time and will reveal the major differences in resource allocation for ...

Lifecycle Management: New Study Reveals $65 Million Investment in New Drug Combinations - New data published today indicates that combinations treatments are a rising trend in the pharmaceutical industry. The average pharmaceutical brand team spends $65 million to ...

[ return to top ]

First Quarter 2005

Pharmaceutical Launch Budgets Top $200 Million - Potential pharmaceutical blockbusters, on average, spent more than $225 million on marketing between Phase III and their first year on the market...

Pharma Competitive Intelligence Budgets Reach $1 Million - Pharmaceutical companies spend upwards of $1 million on their competitive intelligence activities every year...

Pharma’s Early-Phase Marketing Budgets Exceed $20 million - Blockbuster-bound pharmaceutical products get substantial marketing funding in the early development stages...

Blockbuster Drugs with Expiring Patents Gain New Hope - More than $80 billion in blockbuster drugs will face patent expiration and generic competition by 2008...

Pharmaceutical Market Research Spending Reaches $1.9 Million during Critical Launch Stage - Market research budgets rise steadily as products move from Pre-Clinical activities through Phase IIIa...

[ return to top ]

Fourth Quarter 2004

Savings Plan: Banks Boost Retention with Retirement Benefits - As hiring in financial services picks up, banks and insurance companies tout retirement benefits to keep top employees happy...

Vertex and Novartis Restructure Alliance, Bolster Pipelines - With a restructuring of terms to facilitate quicker and earlier transfers of drug candidates to clinical development, Vertex and Norvartis announced their plans to...

Biogenerics Set to Command More Than $12 billion - Generic forms of the first biological drugs threaten to capture significant market share as many of those drugs’ patents will expire over the next few years...

Pharmaceutical Companies Reinvest 10% of Revenues to Extend Product Lines - Drug companies reinvest up to 10% or more of revenues to research and develop franchise and product line extensions...

Tale of the Tape: M&A Heavyweight Bank of America Steps in the Ring - Getting post-merger integration right has always been a tough trick to pull off.  Now, big sectors of the recovering economy face...

Disease Management Programs on the Rise - Disease management is now a $750 million industry that serves approximately 2 million Americans suffering from conditions such as...

[ return to top ]

Third Quarter 2004

18% of  Pharmaceutical Brand Spending Goes to Market Research -The pharmaceutical industry is moving away from viewing market researchers solely as tactical marketing support...

Big Pharmas Beware: Generics Pose Real Threat to Blockbuster Drugs’ Market Share - The Federal Appeals Court handed a major win to Pfizer by rejecting an Indian generic-drug maker's version of Norvasc...

Pharma Sales Reps Spend 20% of Time on Paperwork - US pharmaceutical companies spend more than $4 billion each year on drug detailing, distribution and sample management...

43% of Financial Services Companies Plan to Implement Learning Management System (LMS)
 Within 3 years - Forty-three (43%) percent of companies in the financial services industry plan to roll out a learning management system (LMS) within the next three years to enhance training management...

Pharmaceutical Companies Reach Out to Low-Income Consumers - Forty (40%) of low-income adults failed to fill a prescription in the last year...

[ return to top ]

Second Quarter 2004

Pharma Companies Spend $60 Million on Early-Stage Marketing - Early-stage commercial spending can top $60 million for blockbuster drugs...

Pharmaceutical Compliance Report Stresses Customer Outreach - A wave of disease management programs are forming as companies seek ways to build relationships with physicians and patients...

Generic Pharmaceuticals: Blockbuster Face 80% Loss in Market Share - More than $80 billion worth of blockbuster drugs faces patent expiration by 2008...

67% of Clinical Affairs Departments Track Data Errors, New Study Finds -Two-thirds of pharmaceutical and biotechnology clinical affairs organizations measure data error rates and proactively manage performance based on them...

Competitive Benefits Packages Yield Productive Long-term Employees - Only the US Army has been able to report 100% employee retention in recent years, and the financial services sector represents the other end of the spectrum...

[ return to top ]

First Quarter 2004

IMPAX Labs Carving Out a Foothold in the Cardiovascular Drug Market - IMPAX Laboratories, Inc. announced that the US Food and Drug Administration (FDA) has granted tentative approval for its generic version of Tricor® (Fenofibrate) Tablets...

Biogeneric Approval on its Way? - Forecasters say the market for generic biologic drugs will reach nearly $12 billion worldwide in 2010...

Pharmaceutical Sales Rep Cost $150,000 Apiece - Pharmaceutical sales organizations spend about $150,000 per primary care rep and $330,000 per specialty drug rep...

New Technology Solves Pharma Patient Compliance Woes - Pharma companies that change technology to meet current industry trends consistently meet patient compliance goals...

Call Centers: Only 21% of Calls Lead to Cross-Sell and Up-Sell Opportunities - While companies frequently move call center operations off-shore for better cost-savings, they routinely neglect the fact that only 21% of customer contacts...

[ return to top ]

DECEMBER 2003

Pharmaceutical Compliance: 85% of Prescriptions Never Refilled - Patient compliance is a growing issue—20% of new prescriptions go unfilled, while up to 85% of prescriptions never get refilled...

Pharma-Biotech Alliances:  The New Dominant Industry Strategy - While pharmaceutical companies may be accustomed to continually searching for blockbuster drugs, new strategies assert that...

Successful Pharmaceutical Alliance Managers Use Three-Pronged Management Structure - The most successful pharmaceutical alliances use a three-pronged leadership approach that assigns: 1) a project manager to day-to-day development issues, 2) a BD&L team member to ground-level liaison duties...

Drop the Pitch: New Pharmaceutical Sales Instruments Hit the Right Notes - Who needs another sales pitch? Successful pharmaceutical sales reps shun archaic practices once used and fine-tune new tools to pave a road for lasting physician relationships...

Call Center Agents Come at a Cost:  $15,000 per New Rep - The financial services industry continually wrestles with high turnover in its call centers – and this comes at a huge cost.

[ return to top ]

NOVEMBER 2003

50% of Outsourcing Contracts Include Service Level Agreements - The number of outsourcing deals with Service Level Agreements (SLAs) is increasing from 20% in 2001 to a predicted 50% in 2005...

Call Center Budgets: Credit Cards Companies Lead the Pack - Credit card and financial services companies lead the pack when budgeting for call center activities. According to Purdue University research...

Drug Development Costs Reach All-time High; Pharmaceutical R&D and Marketing Must Unite to Lower Costs - The average cost of bringing a new drug to market has reached an all-time high.  Combined R&D and commercialization costs are approaching...

Pharmaceuticals: Sales Costs Total $31.9 Million per Drug - The pharmaceutical industry averages $31.9 million in annual sales spending for each drug in a primary care portfolio...

[ return to top ]

OCTOBER 2003
Call Center Agents Come at a Cost: $15,000 per New Rep - The financial services industry continually wrestles with high turnover in its call centers...

Follow What Leader?  Corporate America Fails to Plan for the Future - Companies often omit the final and most important step of a succession plan: implementation. When a company roots leadership philosophies in its corporate culture...

60% of Pharmaceutical Co-Promotions Fail, New Study Finds - Pharmaceutical co-promotions have been on the rise, despite new research revealing that 60% of co-promotion alliances in the past five years fail to live up to initial expectations...

Pharmaceutical Outsourcing: New Report Shows Industry Expenditure Tops $30 Billion - The outsourcing trend rose among pharmaceutical companies to become a $30 billion business...

New Drug Approvals on the Rise; R&D and Marketing Unite in Early Development - The FDA approved 15 new molecular entities this year through September 30, 2003, setting the stage to outpace last year’s NME approvals by nearly 20%. The increase in NME approvals shows...

[ return to top ]

SEPTEMBER 2003

Pharmaceutical-Biotechnology Alliances Heat Up - Spending for lucrative biotech alliances rose as the year hit its midpoint...

Call Centers: Outsourcing to India Saves Financial Services Companies $25 Million - Financial service corporations that outsource 1,000 jobs overseas can expect upwards of $25 million in savings...

50% of Pharmaceutical Companies Turn to Sales Reps to Identify Thought Leaders - Field-based pharmaceutical sales reps and medical specialists are the leading resources for identifying thought leaders

Pharmaceutical DTC Spending: $80 million by 2005 - The pharmaceutical industry continues to invest more in direct-to-consumer marketing each year and total spending will range between $70 and $80 million by 2005...

Pharmaceutical R&D Spending Doubles While New Drug Approvals Plummet - New drug approvals plummeted from 53 in 1996 to just 26 in 2002. At the same time, R&D spending nearly doubled from $17 billion in 1996 to $32 billion last year...

[ return to top ]

AUGUST 2003
Succession Planning: Competency-Based Programs Boost Morale 25%  - Competency based human resources programs increase company morale 25%...

Pharmaceuticals: Sales Costs Total $31.9 Million Per Drug - The pharmaceutical industry averages $31.9 million in annual sales spending for each drug in a primary care portfolio...

Call Centers: Financial Services Companies Increase Spending 38%  - The financial services industry increased call center spending by 38% each year since 1999...

Corporate Reputation: 84% of Corporate Leaders Have Low Reputation - Frequent corporate scandals and other negative industry labels cause corporate integrity to deteriorate...

Blockbuster Pharmaceutical Launches: Late-Stage Marketing Budgets On the Rise - Pharmaceutical brand teams spend 46% of their total marketing budgets for individual products during the Launch phase...

Pharmaceutical Industry’s Chief Threat: Failing to Unite R&D and Marketing - Pharmaceutical companies must fight their own internal misalignments as well as external factors such as generic competition and regulatory hurdles...

Pharma Alliances: With M&A Foundering, Companies Turn to Biotech Alliances - Successful pharma mergers achieve 55% to 75% of anticipated cost savings within the first two years and reach full cost savings within three years. Companies unable to sign successful M&A deals turn to...

Pharmaceutical Market Research: 64% of Companies Begin by Phase I  - A recent study highlights the importance of beginning market research activities early in the drug development cycle. Sixty-four percent...

Strategic Outsourcing: 47% of Companies Implement Tactical Outsourcing - Though 47% of companies view outsourcing as a tactical advantage, the current trend finds companies developing strategic outsourcing plans...

[ return to top ]

JULY 2003
Pharmaceutical-Biotechnology Alliances Heat Up - Spending for lucrative biotech alliances rose as the year hit its midpoint...

Pharma Leaders Cut Years Off Drug Development - Pharmaceutical companies sliced almost two years off high-priority products’ development time...

Pharmaceutical Market Research: Phase IIIa Budgets Double Phase II - Pharmaceutical companies boost Phase IIIa market research budgets to an average $1.17 million...

Early-Stage Pharmaceutical Marketing: Pre-Clinical Marketing Tops $2 million- Pharmaceutical companies dedicate an average $2 million and two full-time marketing staffers to pre-clinical blockbuster drug development...

[ return to top ]

JUNE 2003
Pharmaceutical Brand Teams Dedicate 26% Staffing to Market Research - Strong market research staffing makes its impact felt in product commercialization. Market research accounts for 26% of...

CEO Leadership Top Factor in Building Corporate Reputations - Johnson & Johnson leads the pack of the pharmaceutical industry’s most reputable companies for CEO Leadership...

Pharmaceutical-Biotech Alliances: Biotechs Benefit More with Each Successive Deal - Biotechnology firms achieve a 23% average increase in market value after completing several partnership deals...

25% of Companies Lack Formal Succession Plans - While only 25% of companies have a formal succession plan in place, a sound succession strategy can be crucial to the company’s overall success...

Launching Pharmaceutical Blockbusters: Brand Teams Staffed with 26 To 60 FTEs- At the peak of activity, high-profile drug launches earn 60 marketing staff members...

New Guidelines Make Pharmaceutical Sales Tougher - Three recent trends in pharmaceutical sales have altered the landscape for reps, managers, and executives...

[ return to top ]

MAY 2003
Pharma Companies Failing at Local Thought Leader Management - Gaining mindshare among prescribing doctors is critical for a pharmaceutical product’s success...

Pharma Products Need Earlier, Better Planned Spending - Pharmaceutical product teams have improved their spending patterns in the last several years...

E-Detailing Yields Increasing ROI in Pharmaceutical Sales - 43% of scheduled rep visits get cancelled, and 87% of doctor-rep conversations last less than 2 minutes...

Big Mistakes in Succession Planning Strategy - 29% of companies believe they have no need to implement a succession planning system...

Speedy Post-M&A Technology Integration Reduces Costs 30% to 50% - Companies that quickly integrate target systems into existing operations, and do so seamlessly, can see first-year cost savings between 30% and 50%...

[ return to top ]

APRIL 2003
Medical Education: Pharmaceutical Companies Inform Patients - Research estimates that poor health information affects 90 million Americans and costs the health care system tens of billions of dollars annually...

Biotechs Look to Big Pharma Alliances For Growth - 2003 has seen multiple biotechnology firms pair with pharmaceutical companies to collaborate on downstream discovery efforts...

Pharmaceutical Sales Forces to Expand 22%, New Study Says - Top pharmaceutical companies plan to increase sales headcounts by an average 22% over the next 18 to 24 months...

Strategic Outsourcing: 15% Off Outsourcing Research in April - Measurement tracking and continuous improvement are critical factors in post-contract outsourcing management...

Pharmaceutical Blockbuster Launches: Companies Increase DTC Marketing Spend - Pharmaceutical companies spent about $2.6 billion on mass-media ads for prescription drugs in 2002...

Raising Succession Planning to a Top Priority - Recent data indicates that less than 30% of public companies’ boards conduct formal written reviews of their CEOs...

[ return to top ]

MARCH 2003
Poor Brand Management Means Decreased Value - Key metrics show substantial gaps in branding success...

Pharmaceutical Thought Leaders: Building Pre-Clinical Relationships - 25% of pharmaceutical companies begin building long-term thought leader relationships early in the pre-clinical development stage...

Pharmaceutical Research Highlights New Customer Retention Opportunities - Pharmaceutical companies can improve lifetime customer value by positioning themselves as disease experts and providing valuable disease management information...

Pharmaceutical Companies Continue Increasing Biotechnology Investments - Pharmaceutical powerhouses, such as GlaxoSmithKline, have expanded their pipelines to replace billion dollar products by investing in promising drugs from...

Blockbuster Launches: Early-Stage Planning - Pharmaceutical brand teams optimize their early stage resources, allocating 20% of their total marketing budget and 34% of their total marketing staffing to support activities between Phase I and Phase IIIa...

Poor Succession Planning Costs Companies Billions - Even the strongest global companies can lose considerable value when they implement flawed succession plans for top officers...

[ return to top ]

FEBRUARY 2003
Pharmaceutical Thought Leader Programs Start Too Late - Brand teams that implement opinion leader programs in Phase I develop the most beneficial relationships when it comes time to launch ...

Corporate Reputation Helps Companies Outperform the Competition - The companies with the best reputations perform 22% better than average in financial measures ...

Blockbuster Pharmaceutical Launches: Brand Teams Need Increased Funding - Only 47 new drugs hit the market in 2002 – a third fewer than in 1997 ...

Pharmaceutical Lifetime Customer Value: The Internet’s Role - After decades of inability to directly reach patients, the pharmaceutical industry has turned to the Internet ...

Succession Planning: 45% of Top Companies Without Plans - While most executives admit the importance of succession planning, 45% of companies with more than $500 million in sales have no real CEO succession program ...

Pharmaceutical-Biotech Alliances: Biotechs Benefit More with Each Successive Deal - Biotechnology firms achieve a 23% average increase in market value after completing several partnership deals ...

Got Outsourcing? - More than 90% of American companies use outsourcing as a critical tool to reduce overhead and exposure ...

Pharmaceutical Thought Leader Study: Local Opinion Leaders Underused - Regional and national thought leaders are involved in 79% of key pharmaceutical marketing activities ...

Blockbuster Pharmaceutical Launches: Late-Stage Marketing Budgets On The Rise - Pharmaceutical brand teams spend 46% of their total marketing budgets for individual products during the Launch phase ...

[ return to top ]

JANUARY 2003
Is the Pharmaceutical Industry Preparing for More M&A? - Yesterday, Business Week released its pharmaceutical industry analysis stating that one or two big mergers could be in store for 2003 ...

Pharma Companies Tackle Disease Management - Top pharmaceutical companies are developing disease management programs at an increased rate ...

Build Stronger Revenue Streams through Pharma-Biotech Alliances - The Tufts Center for the Study of Drug Development recently announced that pharmaceutical companies are focusing on more secure revenue streams ...

Updated Research Includes Pharmaceutical Marketing Budgets and Staffing - The pharmaceutical industry took a hit in 2002, barely posting positive earnings growth ...

[ return to top ]

DECEMBER 2002
Biotech’s Gearing Up For Strong 2003 - Recent news that five major pharmaceutical firms have no billion-dollar blockbusters in late-stage development highlights the rising importance of pharmaceutical-biotech collaborations ...

Prepare For M&A’s Comeback - The M&A market has backed away from the record highs it posted in 1999 and 2000 due to the slower economy ...

Biotechnology Alliance Funding on the Rise - Following the steady increase in value each year, market analysts estimate that future pharmaceutical-biotechnology collaborations will create even greater shareholder value when managed well ...

Big Pharma Uncovers New Methods to Shorten Time to Launch - Pharmaceutical companies have developed new methods to shorten time-to-launch for new products from an average of 8.5 years to 7 years ...

Patient Assistance Programs Boost Pharmaceutical Lifetime Customer Value - A recent poll indicated that 40% of low-income adults, many of whom are senior citizens, failed to renew necessary prescriptions in the past year ...

Unprepared: American Companies Not Able to Handle Major Crises - The American Management Association recently found that 51% of U.S. companies have no crisis management plans in place ...

Take Me to Your Leader: Strong Succession Planning Begins at the Top - Recent CEO troubles have hobbled some of the world’s largest corporations. In fact, 45% of company boards have no meaningful CEO succession planning process ...

Weathering the Economic Storm through Outsourcing - During an economic downturn, outsourcing is the key to growing market value by billions while decreasing book values ...

[ return to top ]

NOVEMBER 2002
Designing Successful Blockbuster Pharmaceutical Launches - Industry experts estimate 47 new drugs will hit the market in 2002 – a third fewer than in 1997. With each drug carrying more weight ...

Line Specialists Responsible for Companies’ Local Security Success - Local responsibility is necessary to reduce employee breaches and achieve security success ...

M&A Integration: New Report Features More than 250 Metrics - Companies that focus on post-M&A integration activities early, during strategy and planning, and consistently throughout the M&A process find the most success in their consolidation efforts.

Free Pharmaceutical Thought Leader Study Results Available - The study focuses on the most innovative thought leader management programs, detailing how top companies identify top key opinion leaders, increase KOL involvement, collect and disseminate information and build strong relationships that drive product uptake.

Prepare to Compete with the Next Wave of Pharmaceutical Blockbusters - Rapid sales growth for blockbuster products forces major companies to partner with fast-moving biotechs to bulk up pipelines with winners ...

Pharmaceutical Industry Shifts from Product to Customer Focus - New thinking de-emphasizes pharma’s traditional product focus in favor of long-term relationships with the industry’s many customers ...

Mergers and Acquisitions: Poor Planning Yields Poor Results - Failed M&A deals typically result from poor due diligence and inadequate strategic alignment. Companies that look to M&A to penetrate new markets and add shareholder value must ensure they provide enough resources during merger planning to make the combined business successful ...

[ return to top ]

OCTOBER 2002
Building Pharmaceutical Blockbusters: Start with the Right Budget - Pharmaceutical blockbusters are built through intense budgeting and staffing, while failed products often suffer due to insufficient resource allocation ...

Outsourcing Replaces Vertical Integration - New research uncovers how the world’s best companies select which functions to outsource and how to choose the right vendors to meet their needs ...

Managing the Most Valuable Asset: Protecting the Corporate Brand - Brand value made up 90% of some recently acquired companies’ assets. On the other hand, poor brand management in the face of this year’s scandals cut some companies’ brand value by more than half.

New Mergers and Acquisitions Report: M&A Activity Down, Not Out - Though M&A activity is down, companies still consider consolidation a key growth strategy, according to a new report ...

Pharmaceutical Product Launches: Report Features Budgets and Headcounts - As patents expire and product pipelines stumble, pharma companies need new, successful drugs to drive profits and shareholder returns.

New Report Solves the Pharmaceutical Pipeline Problem - Alliances with biotechnology companies will shore up pipelines of pharmaceutical companies ...

Chief Security Officers Must Hold the Line on New Business Tools – The promise of new technologies to boost productivity also brings the threat of major new security challenges ...

Cutting Edge Information today released an updated version of its best-selling report, “Succession Planning for Results.” The updated report contains 50% new information, including detailed succession plans and other development materials from 11 top companies.

[ return to top ]

SEPTEMBER 2002
Pharmaceutical Tools Cultivate Long-Term Customers – The pharmaceutical industry lags behind other sectors in driving the lifetime value of its customers, according to a new report, but that trend is changing ...

Free Pharmaceutical Thought Leader Study Results Available for Participants - Cutting Edge Information launched a new study focused on innovative approaches to managing thought leader programs through medical liaisons and marketing teams ...

80 Key Metrics for Crisis Management and Corporate Reputation show why smart reputation management is becoming a market advantage as the business world looks for stability and trustworthiness ...

Thirty percent of blockbusters originate in alliances and co-development deals. The top ten pharmaceutical companies accounted for 59% of total pharmaceutical sales in 2001, mainly on the strength of ...

Pharmaceutical Compliance: Metrics Reveal New Strategies for Industry Leaders – Pharmaceutical companies face a crisis of compliance: up to 20% of initial prescriptions go unfilled and patients abandon up to 80% of refills ...

Few companies follow through with the rigorous succession planning implementation necessary to build excellent leaders, according to a new report from Cutting Edge Information ...

Some companies are pulling ahead in the race for operational efficiency and effectiveness in the tighter market ...

[ return to top ]

AUGUST 2002
Most admired companies perform 22% better than average in financial measures, and nearly 80% of workers would take a lower salary to work at a company with a better reputation ...

Too often, companies underestimate their brand’s value in sustaining a competitive advantage. Brand value, for example, made up 90% of some recently acquired companies’ assets ...

A strong majority of Chief Security Officers say corporate security is a top priority, but only 8% believe their budgets are appropriately funded ...

While worldwide outsourcing deals are valued at more than $350 billion, only 60% of outsourcing clients are satisfied, according to a new report from Cutting Edge Information ...

Reputation Management Fortifies Companies Against Crisis – In the current atmosphere of uncertainty, companies fall back on reputation management to preserve critical consumer and investor relationships. With ethics experts predicting more scandals in the future ...

Recent CEO failures emphasize leadership selection’s importance, but 45% of the largest companies’ boards have no meaningful CEO succession planning process ...

Pharmaceutical-Biotech Alliances: Strong Opportunities Increasing - Recently announced new deals – and extensions of old ones – emphasize the rising importance of pharma-biotech alliances. Companies that have failed to build alliance strength now lag behind

Key metrics show substantial gaps in branding success, according to a new report from Cutting Edge Information. On the one hand, brand value made up 90% of some recently acquired companies’ assets. On the other, some previously prestigious companies have lost ...

[ return to top ]

JULY 2002
Shareholders Flock to Reputable Companies – Highly regarded companies will make substantial gains as the crisis of confidence recedes and investors return to the market in force. According to recent findings from business intelligence firm Cutting Edge Information, companies showing dedication to ethical accounting and transparent operations build positive reputations that deliver...

Succession Planning Keeps Corporate Growth on Track – Forward-thinking companies align succession planning with corporate strategy to build leaders who spearhead company growth. According to research from Cutting Edge Information, the most elegant succession systems will fail unless they are grounded in company values, a clear growth plan and ...

Pharmaceutical-Biotechnology Partnerships Accelerate Speed-to-Market – Pharmaceutical and biotechnology companies have just begun to tap the potential synergies of their alliances and partnerships, according to research from business intelligence firm Cutting Edge Information. The combination of new biotechnology targets with pharmaceutical ...

Outsourcing Success Banks on Vendor Selection – Companies that master the vendor-selection process derive the greatest benefits from outsourcing. A report from Cutting Edge Information finds that outsourcing veterans evaluate potential partners ...

Succession Planning Builds Ethical Leaders – Companies that implement well-designed succession plans create principled leaders at all levels, according to research from Cutting Edge Information – but rolling out such plans continues to be a critical challenge ...

Premium Pricing Strategies Build on Long-Term Brand Value – Companies seeking to differentiate themselves in the face of globalized competition must carefully manage their corporate brands to succeed, according to research from business intelligence firm Cutting Edge Information. The new research concludes that brand value is

Pharma-Biotech Alliances: Untapped R&D Tools – The figures are stark: Analysts believe that pharmaceutical companies must more than double their research productivity to meet Wall Street growth expectations. Forming alliances with biotech companies is a promising field ...

Clear Security Strategy Gives Employees and Customers Greater Confidence - Top companies use strong, clear security policies to rebuild employee and customer confidence lost to ...

Free Pharma Marketing Study Results Available for Participants - Cutting Edge Information seeks participants for a new study focused on marketing structures and investment patterns that support successful product commercialization and launch ...

Succession Planning Secrets: Working the Plan - While most companies have made commitments to succession planning, few have followed through with the rigorous implementation necessary to build ...

Reputation Management Fortifies Companies Against Crisis - In the current atmosphere of uncertainty, companies fall back on reputation management to preserve consumer and investor relationships ...

[ return to top ]

JUNE 2002
Corporate Security: Companies Still Must Close Dangerous Gaps - Most large companies have still not addressed their most critical security weaknesses ...

Pharmaceutical Outsourcing: New Focus Will Drive Profitability - Several top companies are building competitive advantage through pharmaceutical outsourcing ...

Reputation Management: Companies Shield their Good Names in Today's Crisis - In the past six months, negative publicity has destroyed or severely damaged corporate reputations at a half dozen of the world's ...

Pharma-Biotech Alliances: Solution to Pipeline Woes? - Recent news that five major pharmaceutical firms have no billion-dollar blockbusters in late-stage development highlights ...

Growing the Golden Goose: Turn Brand Equity into Shareholder Value - Brand Value Management is a powerful tool for companies that evolve beyond soft equity strategies and leverage brand value for tangible shareholder gain ...

Pharma-Biotech Alliances: Becoming the Partner of Choice - Huge financial opportunities await pharmaceutical companies that master pharmaceutical-biotech alliances ...

Boosting Brand Value Requires Clear Marketing Strategy - Corporate valuations of companies such as Starbucks and Samsung boomed in 2001 thanks to smart branding strategies ...

Pharma-Biotech Alliances: Finding the Right Partner - Alliances have become critical success factors in one of the world's most profitable industries - pharmaceuticals - and in biotechnology, its vital, innovative counterpart ...

[ return to top ]

MAY 2002
Pharma-Biotech Alliances: Navigating the Minefield - Companies that fail at pharmaceutical-biotech alliances often stumble in the deal-making stage ...

Succession Planning Systems Need Better Execution - Top organizations marry sound planning with consistent execution to forge their companies into "leadership academies" ...

Smart Outsourcing Focuses Top Companies on Core Competencies - Companies that fail to achieve outsourcing success often outsource the wrong functions ...

Corporate Brand Keeps Customers During Economic Uncertainty - Top companies achieve long-term competitive advantage based on customer loyalty to a brand's image and reputation ...

Succession Planning's Missing Link: Execution - Companies that fail at succession planning often lose steam while executing their plans, but top succession planners ...

[ return to top ]

APRIL 2002
Focusing on Core Competencies Requires Savvy Outsourcing - A new report shows how companies have cut costs and streamlined operations by farming out their non-essential work ...

Outsourcing Report Reveals How Vendors Win Business - A new report reveals the processes many top companies use to select vendors ...

Outsourcing From Strength: Cutting Waste and Boosting Shareholder Value - Some of the world's top companies have rejuvenated their valuations through strategic outsourcing initiatives ...

From Molecule to Blockbuster: New Survey Examines How Pharmaceutical Companies Create Marketplace Successes - Business research company Cutting Edge Information seeks participants for a new study focused on pharmaceutical marketplace preparation ...

Free Pharma-Biotech Alliances Study Results Available for Participants - Business research company Cutting Edge Information seeks participants for a new study focused on pharmaceutical-biotechnology alliances ...

[ return to top ]

First Quarter 2002
Double Your Brand Value: New Study Looks at How Top Companies Create Shareholder Value in the 21st Century - The world's best brand management companies treat their brands like other major corporate assets ...

Outsourcing From Strength: Building Focus and Competitive Advantage - The world's top companies have moved beyond using outsourcing to shore up weaknesses ...

[ return to top ]

 
CORPORATE INFO RESEARCH REPORTS CONSULTING NEWS CONTACT US HOME
Copyright (c) Cutting Edge Information  p:919-403-6583  Please read our Copyright Policy